Euro-Med Laboratories Philippines (PHS:EURO) ROCE %: 10.03% (As of Mar. 2026)


PHS:EURO Euro-Med Laboratories Philippines Inc PHS:EURO
83 GF Score
Price ₱1.07
GF Value ₱1.02
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Euro-Med Laboratories Philippines ROCE %?

Euro-Med Laboratories Philippines PHS:EURO -0.93% 83 ROCE % is 10.03% as of Mar. 2026. GuruFocus rates PHS:EURO with a GF Score™ of 83/100 and a GF Value™ of ₱1.02 (Fairly Valued). The stock has 6 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Euro-Med Laboratories Philippines's annualized ROCE % for the quarter that ended in Mar. 2026 was 10.03%.

Euro-Med Laboratories Philippines  (PHS:EURO) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Euro-Med Laboratories Philippines ROCE % Related Terms

Euro-Med Laboratories Philippines ROCE % Historical Data

* Premium members only.

The historical data trend for Euro-Med Laboratories Philippines's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Euro-Med Laboratories Philippines ROCE % Chart

Euro-Med Laboratories Philippines Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.87 7.25 9.90 10.75 13.11

Euro-Med Laboratories Philippines Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.36 10.95 13.41 17.70 10.03
PHS:EURO
83GF Score
Euro-Med Laboratories Philippines Inc PHS:EURO
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Euro-Med Laboratories Philippines ROCE % Calculation

Euro-Med Laboratories Philippines's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=940.874/( ( (10949.905 - 3909.261) + (11144.61 - 3832.621) )/ 2 )
=940.874/( (7040.644+7311.989)/ 2 )
=940.874/7176.3165
=13.11 %

Euro-Med Laboratories Philippines's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=735.316/( ( (11144.61 - 3832.621) + (11110.34 - 3754.351) )/ 2 )
=735.316/( ( 7311.989 + 7355.989 )/ 2 )
=735.316/7333.989
=10.03 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 10.03% mean?
Euro-Med Laboratories Philippines (PHS:EURO) has a ROCE % of 10.03% as of Mar. 2026.
Is Euro-Med Laboratories Philippines' ROCE % too high?
Euro-Med Laboratories Philippines' current ROCE % is 10.03%. The Drug Manufacturers industry median ROCE % is 7.00. Euro-Med Laboratories Philippines' value of 10.03% is 43.4% above this industry median. Overall, Euro-Med Laboratories Philippines has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Euro-Med Laboratories Philippines' ROCE % compare to ZTS and UTHR?
Euro-Med Laboratories Philippines' ROCE % of 10.03% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.00. Euro-Med Laboratories Philippines' value of 10.03% is 43.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.00, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Euro-Med Laboratories Philippines's current ROCE % of 10.03% is 43.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Euro-Med Laboratories Philippines's current ROCE % is 10.03%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Euro-Med Laboratories Philippines stock overvalued right now?
Based on GuruFocus' analysis, Euro-Med Laboratories Philippines (PHS:EURO) is currently considered Fairly Valued. The stock's GF Value™ is ₱1.02, compared to a current price of ₱1.07 — trading 4.9% above its estimated fair value. The current ROCE % is 10.03% and 43.4% above the Drug Manufacturers industry median of 7.00. Euro-Med Laboratories Philippines' overall GF Score™ is 83/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Euro-Med Laboratories Philippines (PHS:EURO), the current ROCE % is 10.03% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Euro-Med Laboratories Philippines (PHS:EURO) Overvalued in 2026?

Based on GuruFocus' analysis, Euro-Med Laboratories Philippines stock appears to be overvalued. The current stock price of ₱1.07 is trading 4.9% above its estimated GF Value™ of ₱1.02. GuruFocus considers Euro-Med Laboratories Philippines to be Fairly Valued.

Key valuation signals for PHS:EURO:

  • ROCE %: 10.03%
  • GF Value™: ₱1.02 vs. price of ₱1.07 (4.9% above fair value)
  • GF Score™: 83/100 with 6 warning signs
  • Industry Position: 43.4% above the Drug Manufacturers median

No single metric tells the full story. See the PHS:EURO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Euro-Med Laboratories Philippines Business Description

Address San Marcelino Street, United Nations Avenue corner, PPL Building, 2nd floor, Manila, PHL, 1000
Euro-Med Laboratories Philippines Inc is a pharmaceutical-based company that engages in the manufacture of pharmaceutical products such as large and small-volume parenterals and other solutions. The company also manufactures sterile water for injection, and other solutions such as ophthalmic, inhalation, irrigation, and dialysis. The Company also manufactures intravenous fluids in glass bottles, hemodialysis concentrates, ophthalmic products and disinfectants.
83GF Score

Get the complete analysis for PHS:EURO

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₱1.07
Price
₱1.02
GF Value